{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:37:26Z","timestamp":1782218246996,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.healun.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T15:29:43Z","timestamp":1471879783000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Avishay","family":"Grupper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Grupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Hathcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando G.","family":"Cosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks S.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir S.","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.08.004_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0b013e31824e7620","article-title":"Steering Group of the UK Cardiothoracic Transplant Audit. Incidence, determinants, and outcome of chronic kidney disease after adult heart transplantation in the United Kingdom","volume":"93","author":"Thomas","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1399-0012.2005.00408.x","article-title":"The natural history of renal function following orthotopic heart transplant","volume":"19","author":"Al Aly","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1681\/ASN.V115951","article-title":"Predictors and evolution of renal function during 9 years following heart transplantation","volume":"11","author":"Lindel\u00f6w","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2016.08.004_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.transproceed.2013.09.031","article-title":"Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study","volume":"46","author":"Gonz\u00e1lez-V\u00edlchez","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/tri.12340","article-title":"Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation","volume":"27","author":"Lachance","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR)","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1053-2498(03)00191-8","article-title":"Renal insufficiency and end-stage renal disease in the heart transplant population","volume":"23","author":"Rubel","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression","volume":"63","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1600-6143.2010.03292.x","article-title":"Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients","volume":"10","author":"Cassuto","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2215\/CJN.02950410","article-title":"An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation","volume":"5","author":"Srinivas","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2016.08.004_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0b013e3181c42248","article-title":"Kidney transplantation in patients with a prior heart transplant","volume":"89","author":"Cassuto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1600-6143.2008.02540.x","article-title":"Kidney transplantation in previous heart or lung recipients","volume":"9","author":"Lonze","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1067\/msy.2001.115834","article-title":"Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience","volume":"130","author":"Coopersmith","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.healun.2016.08.004_bib15","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2016.08.004_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"VENINAHTx-Investigators. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.08.004_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","article-title":"Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation","volume":"125","author":"Topilsky","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.healun.2013.05.015","article-title":"Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation","volume":"32","author":"Matsuo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ki.1986.280","article-title":"Cyclosporine nephrotoxicity","volume":"30","author":"Myers","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2016.08.004_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000168123","article-title":"The spectrum of ciclosporin nephrotoxicity","volume":"10","author":"Puschett","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.healun.2016.08.004_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ki.1991.206","article-title":"Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients","volume":"40","author":"Bertani","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2016.08.004_bib28","first-page":"1114","article-title":"Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group","volume":"27","author":"Porayko","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.08.004_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2016.08.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(99)70101-0","article-title":"Risk for posttransplant Diabetes mellitus with current immunosuppressive medications","volume":"34","author":"Weir","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients","volume":"3","author":"Woodward","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib32","first-page":"775","article-title":"European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results\u2014European Tacrolimus Multicenter Heart Study Group","volume":"17","author":"Reichart","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.08.004_bib33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1034\/j.1600-6143.2003.00186.x","article-title":"Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients","volume":"3","author":"Hathout","year":"2003","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816302856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816302856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:33:18Z","timestamp":1760949198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816302856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1053249816302856"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.08.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc. on behalf of International Society for the Heart and Lung Transplantation","name":"copyright","label":"Copyright"}]}}